UBS Group’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,106,233
| Closed | -$19.9M | – | 11215 |
|
|
2025
Q1 | $19.9M | Buy |
1,106,233
+671,693
| +155% | +$11.9M | ﹤0.01% | 2331 |
|
|
2024
Q4 | $7.59M | Buy |
434,540
+408,295
| +1,556% | +$5.52M | ﹤0.01% | 3364 |
|
|
2024
Q3 | $302K | Buy |
26,245
+4,221
| +19% | +$48.4K | ﹤0.01% | 5566 |
|
|
2024
Q2 | $249K | Sell |
22,024
-26,339
| -54% | -$350K | ﹤0.01% | 5518 |
|
|
2024
Q1 | $693K | Sell |
48,363
-2,879
| -6% | -$40.8K | ﹤0.01% | 4926 |
|
|
2023
Q4 | $703K | Buy |
51,242
+23,196
| +83% | +$244K | ﹤0.01% | 4805 |
|
|
2023
Q3 | $228K | Buy |
28,046
+7,867
| +39% | +$64.3K | ﹤0.01% | 5274 |
|
|
2023
Q2 | $153K | Buy |
20,179
+1,512
| +8% | +$11.5K | ﹤0.01% | 5670 |
|
|
2023
Q1 | $149K | Buy |
18,667
+30
| +0.2% | +$309 | ﹤0.01% | 5610 |
|
|
2022
Q4 | $212K | Buy |
18,637
+15,268
| +453% | +$167K | ﹤0.01% | 5404 |
|
|
2022
Q3 | $30K | Buy |
3,369
+3,072
| +1,034% | +$31.9K | ﹤0.01% | 6896 |
|
|
2022
Q2 | $3K | Sell |
297
-9,339
| -97% | -$94K | ﹤0.01% | 9388 |
|
|
2022
Q1 | $97K | Sell |
9,636
-8,844
| -48% | -$94.1K | ﹤0.01% | 5948 |
|
|
2021
Q4 | $234K | Buy |
+18,480
| New | +$241K | ﹤0.01% | 5553 |
|
|
2021
Q3 | – | Sell |
-800
| Closed | -$12K | – | 10210 |
|
|
2021
Q2 | $12K | Sell |
800
-7,411
| -90% | -$111K | ﹤0.01% | 7908 |
|
|
2021
Q1 | $113K | Sell |
8,211
-775
| -9% | -$12K | ﹤0.01% | 5874 |
|
|
2020
Q4 | $163K | Buy |
8,986
+5,779
| +180% | +$89.2K | ﹤0.01% | 5365 |
|
|
2020
Q3 | $41K | Buy |
+3,207
| New | +$40.2K | ﹤0.01% | 5787 |
|
UBS Group's PTVE Position: Q2 2025 in Review
UBS Group sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 1,106,233 shares — an estimated $19.9M sold.
UBS Group first reported a position in PTVE in Q3 2020 and held it in 18 quarters. The position peaked at $19.9M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- UBS Group reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- UBS Group sold 1,106,233 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $19.9M.
- UBS Group first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 18 quarters.
- UBS Group's Pactiv Evergreen Inc. Common stock position peaked at $19.9M in Q1 2025.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.